BMS-599626

• Description :

  An orally bioavailable pan-HER tyrosine kinase inhibitor with potential antineoplastic activity. BMS-599626 inhibits human epidermal growth factor receptors (HER) HER1, HER2 and HER4, thereby inhibiting the proliferation of tumor cells that overexpress these receptors.

• Shipping Conditions :

  RT

• Storage Conditions :

  -20°C

• Shelf Life :

  24months